Abstract: A lead compound emerging from these investigations, spiro[5.5]undecan-3-amine, is an effective inhibitor of wild-type A/
M2 channels and
L26F and
V27A mutant ion channels in vitro and also inhibits replication of recombinant mutant viruses bearing these mutations in plaque reduction assays.
Abstract: The A/
M2 proton channel of influenza A virus is a target for the anti-influenza drugs amantadine and rimantadine, whose effectiveness was diminished by the appearance of naturally occurring point mutants in the A/
M2 channel pore, among which the most common are
S31N,
V27A, and
L26F.
Introduction: Although the
S31N mutation was observed in more then 90% of influenza A ca